N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

An Artificial Intelligence-Powered Supportive Care Chatbot to Address the Supportive Care Needs of Young Adult Cancer Survivors

Sponsor: University of Michigan Rogel Cancer Center • ClinicalTrials.gov ID: NCT07772596

Registry updated: 2026-10-15
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This clinical trial studies whether an artificial intelligence (AI)-powered supportive care chatbot is helpful for addressing the supportive care needs of young adult cancer survivors. Young adult cancer survivors often experience ongoing and distressing symptoms following treatment, including extreme tiredness and lack of energy, anxiety, and difficulty sleeping. Young adult cancer survivors report a variety of strategies to self-manage these symptoms; however, there remains a gap in targeted interventions focused on the needs in young adult survivors. The AI-powered supportive care chatbot is designed to provide evidence-based information on supportive care for young adult cancer survivors. Users interact with the chatbot by entering free-text questions or selecting from predefined topics to receive tailored educational responses related to supportive care across the cancer continuum, including treatment effects, symptom management, care transitions, and life after cancer. The AI-powered supportive care chatbot may be an effective way to help address the supportive care needs of young adult cancer survivors.

Interventions

  • Artificial Intelligence-based Intervention (Other)
    Interact with AI-powered supportive care chatbot
  • Interview (Other)
    Ancillary studies
  • Survey Administration (Other)
    Ancillary studies

Eligibility criteria

Inclusion Criteria: * 18 - 39 years old * Able to speak/read English * Completed primary cancer treatment (e.g., surgery, radiation, chemotherapy, immunotherapy) at least one month prior to the time of consent. Although, participants will be eligible if they are receiving maintenance treatments * Report at least one moderate to severe symptom, side effect, or supportive care concern from cancer or its treatment * Able to access Wi-Fi/internet * Willing to complete surveys electronically Exclusion Criteria: * Completed cancer treatment more than three years ago

Conditions

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Locations

  • University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record